Effects of high altitude on respiratory rate and oxygen saturation reference values in healthy infants and children younger than 2 years in four countries: a cross-sectional study
Mary E. Crocker, Shakir Hossen, Dina Goodman, Suzanne Simkovich, Miles A. Kirby, Lisa M. Thompson, Ghislaine Rosa, Sarada S. Garg, Gurusamy Thangavel, Eric D. McCollum, Jennifer L. Peel, Thomas Clasen, William Checkley
Abstract
BACKGROUND: by age and altitude at four sites, with altitudes ranging from sea level to 4348 m. METHODS: thresholds for tachypnoea and hypoxaemia to determine agreement. FINDINGS: against the WHO cutoffs, we found that the proportion of false positives for tachypnoea increased with altitude: 0% in India (95% CI 0-0), 7·3% in Guatemala (4·1-10·4), 16·8% in Rwanda (12·9-21·1), and 28·9% in Peru (23·7-33·0). We also found a high proportion of false positives for hypoxaemia in Peru (11·6%, 95% CI 7·0-14·7). INTERPRETATION: was in reasonable agreement with the WHO definition of hypoxaemia in all regions except for Peru (the highest altitude site). Misclassifications could result in inappropriate management of paediatric respiratory illness and misdirection of potentially scarce resources such as antibiotics and supplemental oxygen. Future studies at various altitudes are needed to validate our findings and recommend a revision to current guidelines. Substantiating research in sick children is still needed. FUNDING: US National Institutes of Health, Bill & Melinda Gates Foundation.